Pneumococcal Conjugate Vaccines (PCV)

Type: vaccine

Status: FDA Approved

Developer: Pfizer (Prevnar 13, Prevnar 20), Merck (Vaxneuvance)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026